StockData
CBDYOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Target Group Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$431.92K
P/E (TTM)
–
Dividend yield
–

About Target

Medicinal Chemicals & Botanical Products, SIC 2833

Target Group Inc. cultivates, processes, and distributes curated cannabis goods for Canada's medical and adult-use recreational markets. Through subsidiaries such as Canary Rx Inc. and CannaKorp Inc., it provides wholesale and co-packaging services for consumer-packaged cannabis products, integrating research, testing, development, and manufacturing. Its portfolio includes flower and extract vaporizer pods, pre-rolls, infused beverages, infused coffee and tea pods, edibles, and CBD wellness items. The business primarily targets legal wholesale and commercial partners within the cannabis industry, as well as end consumers seeking medical or recreational products.

The company operates primarily in Canada through Canary, which leases a 44,000-square-foot indoor cultivation facility in Norfolk County, Ontario, featuring eight flower rooms and licensing to produce approximately 3,600 kilograms of dried cannabis flower annually. Target Group employs 40 individuals as of late 2025 and maintains no corporate offices, operations, or staff in the United States. Its principal executive office is situated in Hamilton, Ontario, Canada.

Summary of the business section of Target's latest annual report, written by StockData.

Company profile

Company

Legal name
Target Group Inc.
Founded
2013
Headquarters
Hamilton, Ontario, Canada
Address
20 Hempstead Drive L8W 2E7
Phone
(905) 541-3833
Employees
40, Dec 31, 2025
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Fruci & Associates II, PLLC, Spokane, Washington

Stock & identifiers

Ticker
CBDY
Exchange
OTC
Shares outstanding
617M, Aug 13, 2026
Public float
$4.63M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-1000 reverse, Nov 1, 2017
SEC CIK
1586554
EIN
46-3610035

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

Target's leadership is listed in its proxy statement (Form DEF 14A).

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 40 employees which include Anthony Zarcone, Chief Executive Officer.”

Corporate history

Events identified from SEC filings

DateEventDetails
Mar 31, 2020Late filingNotification of late filing
Nov 15, 2019Late filingNotification of late filing
Aug 15, 2019Late filingNotification of late filing
May 16, 2019Late filingNotification of late filing
Aug 8, 2018Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jul 3, 2018Name changeName changed from Chess Supersite Corp to Target Group Inc.
Feb 6, 2017Auditor changeChange in certifying accountant (8-K Item 4.01)
Dec 11, 2014Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 13, 2014Name changeName changed from River Run Acquisition Corp to Chess Supersite Corp